Regulatory & Legal

Galloway Capital Partners takes a 5.44% stake in Chegg, arguing the ed-tech firm is undervalued and a strategic split could revive its fortunes.

Absci will showcase its generative AI drug discovery platform at a key healthcare conference, highlighting its ambitious pipeline for hair loss and endometriosis.

As Spectral AI preps its revolutionary DeepView wound scanner for launch, new CFO David McGuire brings crucial public company expertise to a pivotal transition.

Ovid Therapeutics is spotlighting a novel drug class targeting KCC2, a key brain protein. Could this be the key to treating psychosis and epilepsy?

After a Nasdaq delisting for compliance failures, Captivision is abandoning its tech past for a risky new venture: a gold rush in Montana.

A major broadband project finishes early, bringing high-speed internet to thousands in underserved areas and future-proofing the state for a digital economy.

Amid global volatility, B2PRIME Group announced record 2025 profits, a 5x surge in volume, and eliminated all debt, setting a new bar for resilience.

TAE Life Sciences' new therapy combines precision radiation with immunotherapy, showing 100% tumor regression in preclinical studies for hard-to-treat cancers.

With new President Vik Shah and SVP Kevin Hoban, North America's top truck body maker eyes innovation and efficiency amid profound industry shifts.

Celebrating a decade of challenging norms, AESARA eyes its next chapter in global health, armed with AI, RWE, and a focus on complex diseases.

A massive data park in Nobles County promises a $30M community fund and huge tax revenues, but faces scrutiny over its environmental footprint.

A new national report quantifies the huge economic and social benefits of affordable housing, even as the system buckles under soaring demand and neglect.

The eyecare tech leader will demo its redesigned EHR at ASCRS 2026, promising streamlined workflows. But can it stand out in a competitive market?

A stunning Q1 2026 revival shows SPACs are not dead. Fueled by veteran sponsors and a focus on AI and defense, a new era for public listings may be dawning.

One CEO is cycling from Mexico to Canada to directly hand out $1 million, challenging traditional charity and spotlighting towns the interstate left behind.

Rune Labs launches StrivePD Guardian, an AI companion using Anthropic's Claude and a massive dataset to offer 24/7 personalized support for patients.

Online pharmacies in India and telehealth firms in New Zealand now face a mandatory certification to advertise on Google, raising both standards and costs.

The firm expands its Target Outcome ETF suite with three new funds designed to manage timing risk and provide investors with defined downside protection.

With its future riding on a pivotal trial for avexitide, Amylyx's upcoming conference presentation offers a crucial look into its post-ALS strategy.

AEGIS Markets' record Q1 signals a seismic shift in commodity hedging, as firms ditch old methods for transparent, regulated digital platforms.